Related Experiment Videos
Depression in Parkinson's disease: identification and management
1Schools of Medicine and Pharmacy, Loma Linda University, Loma Linda, California.
Pharmacotherapy
|June 26, 2013
Summary
Depression is a common comorbidity in Parkinson's disease (PD), impacting quality of life. Effective treatment requires monitoring and a multimodal approach combining psychotherapy and pharmacotherapy.
Area of Science:
- Neurology
- Psychiatry
- Gerontology
Background:
- Depression frequently co-occurs with Parkinson's disease (PD), significantly impairing cognitive, functional, motor, and social performance.
- This comorbidity reduces patient quality of life, increases care dependency, and burdens caregivers.
Purpose of the Study:
- To review a general approach to the pharmacotherapy of depression in Parkinson's disease.
- To emphasize the importance of monitoring treatment response and utilizing a multimodal therapeutic strategy.
Main Methods:
- Review of current literature and clinical guidelines for managing depression in PD.
- Discussion of pharmacologic and psychotherapeutic treatment options.
Main Results:
- Depression in PD necessitates careful monitoring and individualized treatment plans.
- A combination of pharmacotherapy and psychotherapy is recommended for optimal outcomes.
Conclusions:
- Clinicians should base treatment decisions on risk-benefit assessments for each patient.
- Early engagement of mental health services and an individualized multimodal approach are crucial for comprehensive care in Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...